NASDAQ:CSBR Champions Oncology Q2 2027 Earnings Date & Estimates $4.34 -0.06 (-1.45%) As of 03:58 PM Eastern This is a fair market value price provided by Massive. Learn more. Champions Oncology is estimated to report Q2 2027 earnings on Tuesday, December 15, 2026, after market closes. The conference call is scheduled for December 14, 2026 at 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ2 2027Announcement DateDecember 15, 2026TimeAfter Market ClosesConference Call DateDecember 14, 2026Conference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Champions Oncology in Q2 2027Champions Oncology is expected to post earnings of $0.02 per share on revenue of $16.37 million. Champions Oncology last reported on September 10, 2026, posting $0.05 per share and beating the -$0.01 consensus estimate. Champions Oncology has beaten the consensus EPS estimate in 3 of its last 4 quarters.Consensus EstimatesConsensus EPS$0.02Expected Revenue$16.37 millionRecent Track RecordLast ReportedQ1 2027Last Quarter EPS$0.05 (Beat by +$0.06)Last Quarter Revenue$15.23 millionEPS Beat Rate3 of last 4 quartersPrepare for the Q2 2027 CallEarnings HistoryCompany ProfileQ1 2027 Earnings ReportQ4 2026 Earnings ReportQ4 2025 Earnings Report Champions Oncology Q2 2027 Earnings FAQ When does Champions Oncology report Q2 2027 earnings? Champions Oncology (NASDAQ:CSBR) is estimated to report Q2 2027 earnings on Tuesday, December 15, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Champions Oncology's Q2 2027 earnings call? Champions Oncology's Q2 2027 earnings conference call is scheduled for Monday, December 14, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Champions Oncology? Analysts expect Champions Oncology to post earnings of $0.02 per share for Q2 2027. How much revenue is Champions Oncology expected to report? The consensus revenue estimate for Champions Oncology is $16.37 million for Q2 2027. Champions Oncology Earnings HeadlinesChampions Oncology Stockholders Approve Governance and Incentive PlanOctober 16, 2026 | tipranks.comChampions Oncology, Inc. (CSBR) Q1 2027 Earnings Call TranscriptSeptember 10, 2026 | seekingalpha.comEarn $4,500 a month? Your income may count for moreEarn $4,500 or more a month? Pennie lets you explore personal loan options that consider your income, not just your credit score. Options include personal loans up to $250,000 and APRs starting at 5.99%. Checking your rate is free, and the soft credit check won't affect your score. Pennie is a loan marketplace, not a lender. Offers come from third-party partners and are not guaranteed.November 20 at 1:00 AM | Pennie Financial (Ad)Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026September 4, 2026 | finance.yahoo.comChampions Oncology, Inc. (CSBR) Q4 2026 Earnings Call TranscriptJuly 27, 2026 | seekingalpha.comChampions Oncology, Inc.: Champions Oncology Reports Record Annual Revenue of $59 MillionJuly 27, 2026 | finanznachrichten.deSee More Champions Oncology Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Champions Oncology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Champions Oncology and other key companies, straight to your email. Email Address About Champions OncologyChampions Oncology (NASDAQ:CSBR) is a biotechnology company focused on cancer research and precision oncology. It develops and uses patient-derived tumor models and related technologies to study how cancers respond to treatments. The company provides research services to biopharmaceutical firms developing cancer therapies, including preclinical testing and translational research. It also offers tumor-profiling and treatment-testing services intended to help physicians evaluate potential therapies for individual patients. Champions Oncology was founded in 2007 and serves pharmaceutical and biotechnology customers as well as the oncology community. Its work centers on connecting laboratory research with clinical cancer care.View Champions Oncology ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItAirfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter TestHard Drives Were Left for Dead, But Seagate and Western Digital Are SoaringPalo Alto Networks' Q1 Beat Gives Its Stock Rally Another Reason to RunGrand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.